FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2541346513> ?p ?o ?g. }

• W2541346513 endingPage "2624" @default.
• W2541346513 startingPage "2617" @default.
• W2541346513 abstract "Objective: The Protease Inhibitor Monotherapy Versus Ongoing Triple Therapy (PIVOT) trial found that protease inhibitor monotherapy as a simplification strategy is well tolerated in terms of drug resistance but less effective than combination therapy in suppressing HIV viral load. We sought to identify factors associated with the risk of viral load rebound in this trial. Methods: PIVOT was a randomized controlled trial in HIV-positive adults with suppressed viral load for at least 24 weeks on combination therapy comparing a strategy of physician-selected ritonavir-boosted protease inhibitor monotherapy versus ongoing triple therapy. In participants receiving monotherapy, we analysed time to confirmed viral load rebound and its predictors using flexible parametric survival models. Results: Of 290 participants initiating protease inhibitor monotherapy (80% darunavir, 14% lopinavir, and 6% other), 93 developed viral load rebound on monotherapy. The risk of viral load rebound peaked at 9 months after starting monotherapy and then declined to approximately 5 per 100 person-years from 18 months onwards. Independent predictors of viral load rebound were duration of viral load suppression before starting monotherapy (hazard ratio 0.81 per additional year <50 copies/ml; P < 0.001), CD4+ cell count (hazard ratio 0.73 per additional 100 cells/μl for CD4+ nadir; P = 0.008); ethnicity (hazard ratio 1.87 for nonwhite versus white, P = 0.025) but not the protease inhibitor agent used (P = 0.27). Patients whose viral load was analysed with the Roche TaqMan-2 assay had a 1.87-fold risk for viral load rebound compared with Abbott RealTime assay (P = 0.012). Conclusion: A number of factors can identify patients at low risk of rebound with protease inhibitor monotherapy, and this may help to better target those who may benefit from this management strategy." @default.
• W2541346513 created "2016-11-04" @default.
• W2541346513 creator A5008173217 @default.
• W2541346513 creator A5013078758 @default.
• W2541346513 creator A5035679710 @default.
• W2541346513 creator A5038362714 @default.
• W2541346513 creator A5045561324 @default.
• W2541346513 creator A5056392452 @default.
• W2541346513 creator A5060324723 @default.
• W2541346513 creator A5060349311 @default.
• W2541346513 creator A5062184568 @default.
• W2541346513 creator A5080467252 @default.
• W2541346513 creator A5085619123 @default.
• W2541346513 date "2016-11-13" @default.
• W2541346513 modified "2023-10-02" @default.
• W2541346513 title "Factors associated with virological rebound in HIV-infected patients receiving protease inhibitor monotherapy" @default.
• W2541346513 cites W1918234658 @default.
• W2541346513 cites W1967974256 @default.
• W2541346513 cites W1984820496 @default.
• W2541346513 cites W1985473260 @default.
• W2541346513 cites W1989372408 @default.
• W2541346513 cites W1991644509 @default.
• W2541346513 cites W1994313952 @default.
• W2541346513 cites W2011134834 @default.
• W2541346513 cites W2027805746 @default.
• W2541346513 cites W2034930893 @default.
• W2541346513 cites W2041451020 @default.
• W2541346513 cites W2070036973 @default.
• W2541346513 cites W2106129338 @default.
• W2541346513 cites W2116465729 @default.
• W2541346513 cites W2131795108 @default.
• W2541346513 cites W2135369095 @default.
• W2541346513 cites W2147662860 @default.
• W2541346513 cites W2152673963 @default.
• W2541346513 cites W2154782100 @default.
• W2541346513 cites W2159560061 @default.
• W2541346513 cites W2164734631 @default.
• W2541346513 cites W2313804255 @default.
• W2541346513 cites W2323185049 @default.
• W2541346513 cites W2409182456 @default.
• W2541346513 cites W2418926660 @default.
• W2541346513 doi "https://doi.org/10.1097/qad.0000000000001206" @default.
• W2541346513 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27456983" @default.
• W2541346513 hasPublicationYear "2016" @default.
• W2541346513 type Work @default.
• W2541346513 sameAs 2541346513 @default.
• W2541346513 citedByCount "17" @default.
• W2541346513 countsByYear W25413465132016 @default.
• W2541346513 countsByYear W25413465132017 @default.
• W2541346513 countsByYear W25413465132018 @default.
• W2541346513 countsByYear W25413465132019 @default.
• W2541346513 countsByYear W25413465132020 @default.
• W2541346513 crossrefType "journal-article" @default.
• W2541346513 hasAuthorship W2541346513A5008173217 @default.
• W2541346513 hasAuthorship W2541346513A5013078758 @default.
• W2541346513 hasAuthorship W2541346513A5035679710 @default.
• W2541346513 hasAuthorship W2541346513A5038362714 @default.
• W2541346513 hasAuthorship W2541346513A5045561324 @default.
• W2541346513 hasAuthorship W2541346513A5056392452 @default.
• W2541346513 hasAuthorship W2541346513A5060324723 @default.
• W2541346513 hasAuthorship W2541346513A5060349311 @default.
• W2541346513 hasAuthorship W2541346513A5062184568 @default.
• W2541346513 hasAuthorship W2541346513A5080467252 @default.
• W2541346513 hasAuthorship W2541346513A5085619123 @default.
• W2541346513 hasBestOaLocation W25413465132 @default.
• W2541346513 hasConcept C126322002 @default.
• W2541346513 hasConcept C142462285 @default.
• W2541346513 hasConcept C203014093 @default.
• W2541346513 hasConcept C207103383 @default.
• W2541346513 hasConcept C2776999253 @default.
• W2541346513 hasConcept C2777182164 @default.
• W2541346513 hasConcept C2778414717 @default.
• W2541346513 hasConcept C2779182219 @default.
• W2541346513 hasConcept C2779298103 @default.
• W2541346513 hasConcept C2781143361 @default.
• W2541346513 hasConcept C2993143319 @default.
• W2541346513 hasConcept C3013748606 @default.
• W2541346513 hasConcept C44249647 @default.
• W2541346513 hasConcept C71924100 @default.
• W2541346513 hasConcept C90924648 @default.
• W2541346513 hasConceptScore W2541346513C126322002 @default.
• W2541346513 hasConceptScore W2541346513C142462285 @default.
• W2541346513 hasConceptScore W2541346513C203014093 @default.
• W2541346513 hasConceptScore W2541346513C207103383 @default.
• W2541346513 hasConceptScore W2541346513C2776999253 @default.
• W2541346513 hasConceptScore W2541346513C2777182164 @default.
• W2541346513 hasConceptScore W2541346513C2778414717 @default.
• W2541346513 hasConceptScore W2541346513C2779182219 @default.
• W2541346513 hasConceptScore W2541346513C2779298103 @default.
• W2541346513 hasConceptScore W2541346513C2781143361 @default.
• W2541346513 hasConceptScore W2541346513C2993143319 @default.
• W2541346513 hasConceptScore W2541346513C3013748606 @default.
• W2541346513 hasConceptScore W2541346513C44249647 @default.
• W2541346513 hasConceptScore W2541346513C71924100 @default.
• W2541346513 hasConceptScore W2541346513C90924648 @default.
• W2541346513 hasIssue "17" @default.
• W2541346513 hasLocation W25413465131 @default.
• W2541346513 hasLocation W25413465132 @default.

• next